|
CCDC163P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.280200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.595200E-01 |
| Normal-vs-Stage2 |
4.131000E-01 |
| Normal-vs-Stage3 |
7.546100E-02 |
| Normal-vs-Stage4 |
3.394800E-01 |
| Stage1-vs-Stage2 |
1.369800E-01 |
| Stage1-vs-Stage3 |
1.843240E-01 |
| Stage1-vs-Stage4 |
2.615800E-01 |
| Stage2-vs-Stage3 |
4.199800E-02 |
| Stage2-vs-Stage4 |
4.816800E-01 |
| Stage3-vs-Stage4 |
1.886760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.055800E-01 |
| Normal-vs-AfricanAmerican |
1.036190E-01 |
| Normal-vs-Asian |
1.780580E-01 |
| Caucasian-vs-AfricanAmerican |
2.213900E-02 |
| Caucasian-vs-Asian |
3.399400E-01 |
| AfricanAmerican-vs-Asian |
6.210600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.638000E-01 |
| Normal-vs-Female |
6.976600E-01 |
| Male-vs-Female |
8.799200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.234600E-01 |
| Normal-vs-Extreme_Weight |
5.800000E-01 |
| Normal-vs-Obese |
9.050200E-01 |
| Normal-vs-Extreme_Obese |
6.643600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.376200E-01 |
| Normal_Weight-vs-Obese |
7.481000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.515900E-02 |
| Extreme_Weight-vs-Obese |
6.545800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.488300E-02 |
| Obese-vs-Extreme_Obese |
3.780400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.697600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.064800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.609200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.045800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.991960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.505800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.055600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.988100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.354830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.238000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.351400E-01 |
| Normal-VS-Type2 PRCC |
4.719600E-01 |
| Normal-VS-KIRP CIMP |
8.332800E-01 |
| Normal-VS-Unclassified PRCC |
4.144800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.233000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.634000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.512800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.832400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.814240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.415000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.027000E-01 |
| Normal-vs-N1 |
4.231600E-01 |
| Normal-vs-N2 |
7.250000E-01 |
| N0-vs-N1 |
1.928210E-01 |
| N0-vs-N2 |
3.667800E-01 |
| N1-vs-N2 |
8.479000E-01 |
|
|
